• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME MONITOR Back to Search Results
Catalog Number 07671687016
Device Problem High Test Results (2457)
Patient Problems Stroke/CVA (1770); Dizziness (2194)
Event Date 04/23/2022
Event Type  Injury  
Manufacturer Narrative
The customer's meter and test strips were requested for investigation.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.The returned test strips were measured with the returned meter with a high level control sample.Testing results (qc range = 2.4 - 3.0 inr): qc measurement 1 = 2.8 inr.Qc measurement 2 = 2.7 inr.Qc measurement 3 = 2.8 inr.All inr values were within the specified target ranges and no error messages occurred.Upon review of the meter's patient result memory, the alleged value of "around 5" inr on 23-apr-2022 was not observed.Per product labeling: "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." medwatch field occupation the occupation is patient's wife.
 
Event Description
The patient's wife alleged that the patient received a questionable result when testing with coaguchek inrange meter serial number (b)(4).It was alleged the patient suffered a stroke approximately (b)(6)2022.Allegedly on (b)(6)2022, the patient tested on the meter and the result was "around 5" inr as reported by the patient's wife to one of the patient's physicians.The patient allegedly did not feel well and was dizzy.It was reported that the patient went to the hospital and the doctors said the patient had a stroke.Within 3 hours of the meter measurement, a sample from the patient was tested in the hospital laboratory using an unknown method, resulting in an alleged value of 3.8 inr.It was reported that the doctor concluded the meter was defective and prescribed another coaguchek device.The patient's therapeutic range is (b)(6).It was reported the patient has now returned home from the hospital without any after effects.The patient was reported to have been doing well and received aspirin treatment in addition to his warfarin treatment.Examples of information requested, but not provided at this time include patient details, including age, medical history, and medications taken.Diagnostic tests performed and results.The type of stroke (hemorrhagic or thromboembolic).Information on therapy provided to the patient at the hospital.Other inr measurements performed on the meter.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
Evaluation method coding has been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST PST
Type of Device
PROTHROMBIN TIME MONITOR
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14497365
MDR Text Key294663812
Report Number1823260-2022-01480
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number07671687016
Device Lot NumberASKU
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/17/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/29/2022
Initial Date FDA Received05/25/2022
Supplement Dates Manufacturer Received05/24/2022
Supplement Dates FDA Received06/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ACETYLLEUCINE; ASPIRIN; WARFARIN
Patient Outcome(s) Hospitalization;
Patient SexMale
-
-